Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;19(4):197-206.
doi: 10.1016/j.jsps.2011.06.003. Epub 2011 Jun 25.

Vaccine adjuvants - Current status and prospects on controlled release adjuvancity

S M Sivakumar  1 , Mohammed M Safhi, M Kannadasan, N Sukumaran
Affiliations

Vaccine adjuvants - Current status and prospects on controlled release adjuvancity

S M Sivakumar et al. Saudi Pharm J. 2011 Oct.

Abstract

The strategy of World Health Organization is to develop efficient and inexpensive vaccine against various infectious diseases amongst children's population. Vaccination is considered as the most cost effective health intervention known to public. Since 90 years various substances have been added in vaccine formulation but still alum is considered as the safest adjuvant for human use licensed by United States Food and Drug Administration. MF 59 and ASO4 are the adjuvants were developed recently and approved for human use. Due to poor adjuvancity, conventional vaccines require multiple recall injection at approximately time intervals to attain optimal immune response. For past approximately two decades the vaccine research has been focused towards the alternation of alum type of adjuvant in order to increase the immunogenicity. The development of new vaccines, is more efficacious or easier to deliver, or both have become an area of research that can certainly benefit from controlled release technology. Especially, the conversion of multiple administration vaccine into single administration vaccine may represent an improved advancement towards the betterment of human health care and welfare. Biodegradable polymer microparticles have been evaluated for delivering antigens in native form, sustained release keeping in mind the safety aspects. In this article we review the overall concept of adjuvants in vaccine technology with special focus towards the prospects of controlled release antigens.

Keywords: Adjuvant and its types; Biodegradable polymers; Immune response; Microparticles; Vaccine delivery.

PubMed Disclaimer

References

    1. Achal P., Nicholas M.V., Jerry B.U. Targeting the innate immune response with improved vaccine adjuvants. Nat. Med. 2005;11(4):S63–S68. - PubMed
    1. Aguilar J.C., Rodriguez E.G. Vaccine adjuvants revisited. Vaccine. 2007;25:3752–3762. - PubMed
    1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. - PubMed
    1. Allison A.C., Byars N.E. Immunological adjuvants: desirable properties and side-effects. Mol. Immunol. 1991;28(3):279–284. - PubMed
    1. Allison A.C., Gregoriadis G. Liposomes as immunological adjuvants. Nature. 1974;252:252–258. - PubMed